ADPKD (Autosomal Dominant Polycystic Kidney Disease)
8
3
3
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (8)
Drug-Drug Interactions of JMKX003142 in Healthy Participants
Bempedoic Acid Therapy for Polycystic Kidney Disease
The German ADPKD Tolvaptan Treatment Registry
A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults
Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers
Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment
Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects